DEUTSCHE BANK AG\ - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 52 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,601,000
+8.3%
1,647,000
+11.7%
0.00%0.0%
Q3 2021$1,478,000
-21.8%
1,475,000
-22.8%
0.00%0.0%
Q2 2021$1,889,000
-15.2%
1,911,000
-11.2%
0.00%0.0%
Q1 2021$2,228,000
+41.8%
2,153,000
+29.0%
0.00%0.0%
Q4 2020$1,571,000
+9.2%
1,669,000
+4.7%
0.00%0.0%
Q3 2020$1,438,000
+167.8%
1,594,000
+145.2%
0.00%
Q1 2020$537,000
-72.9%
650,000
-71.7%
0.00%
-100.0%
Q4 2019$1,980,000
-14.3%
2,295,000
-17.3%
0.00%
-50.0%
Q3 2019$2,311,000
-74.6%
2,774,000
-73.7%
0.00%
-60.0%
Q2 2019$9,102,00010,545,0000.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders